Kezar Life Sciences Cash from Financing (TTM) Trends

Kezar Life Sciences Inc (KZR)

0.8548 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

0.8548 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.638M
September 30, 2023	1.085M
June 30, 2023	1.227M
March 31, 2023	79.17M
December 31, 2022	127.86M
September 30, 2022	226.71M
June 30, 2022	228.74M
March 31, 2022	150.70M
December 31, 2021	112.58M
September 30, 2021	13.55M
June 30, 2021	13.30M
March 31, 2021	57.01M
December 31, 2020	99.64M

Date	Value
September 30, 2020	99.40M
June 30, 2020	97.45M
March 31, 2020	53.64M
December 31, 2019	0.272M
September 30, 2019	0.197M
June 30, 2019	-0.898M
March 31, 2019	77.89M
December 31, 2018	77.91M
September 30, 2018	77.91M
June 30, 2018	86.34M
March 31, 2018	49.78M
December 31, 2017	49.76M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.898M

Minimum

Jun 2019

228.74M

Maximum

Jun 2022

71.70M

Average

57.01M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks